Noema Pharma Appoints Michael Samar as Chief Financial Officer and Volker Knappertz as Executive Vice President of Research and Development
Position
Vice President of Research and Development
Company
Noema Pharma
BaselBiotechnologyHealth CareTherapeuticsDescription
Noema Pharma, a clinical-stage biotech company focusing on CNS disorders, has appointed Michael Samar as Chief Financial Officer. In addition, Volker Knappertz, M.D., has been appointed as Executive Vice President of Research and Development.
Quick answer
Noema Pharma Appoints Michael Samar as Chief Financial Officer and Volker Knappertz as Executive Vice President of Research and Development (January 8, 2025). Noema Pharma is based in Basel, Basel City, Switzerland.
- Who is the new Vice President of Research and Development at Noema Pharma?
- Noema Pharma named Volker Knappertz Vice President of Research and Development, announced January 8, 2025.
- What did Noema Pharma announce on January 8, 2025?
- Noema Pharma, a clinical-stage biotech company focusing on CNS disorders, has appointed Michael Samar as Chief Financial Officer. In addition, Volker Knappertz, M.D., has been appointed as Executive Vice President of Research and Development.
- What does Noema Pharma do?
- Noema Pharma is a clinical-stage biotech company advancing a portfolio of transformative, first-in-disease therapeutics targeting neuroscience-based conditions with high unmet need.
- Where is Noema Pharma based?
- Noema Pharma is based in Basel, Basel City, Switzerland.
- Which similar companies made leadership changes around the same time?
- Actio Biosciences (January 8, 2025), Centessa Pharmaceuticals plc (January 8, 2025), AiCuris Anti-infective Cures AG (January 8, 2025) and GEMMABio (January 9, 2025) also announced leadership changes within 45 days of Noema Pharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Actio Biosciences Appoints Cayce Denton as Chief Financial Officer (January 8, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Aicuris Appoints Jacques Dumas, Ph.D., as Chief Scientific Officer (January 8, 2025)
- GEMMABio Appoints May Orfali, MD, MBA, as Chief Medical Officer (January 9, 2025)
- MitoRx Therapeutics Appoints Dr. Lubor Gaal as Chief Business Officer and Stacey Massey as Finance Director (January 9, 2025)
- Nimbus Therapeutics appoints Peter J. Tummino, Ph.D. as President of Research and Development (January 9, 2025)
Who to call at Noema Pharma, and when
A new leader at Noema Pharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Noema Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Noema Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Noema Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Noema Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Noema Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.